Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
11 Nov 2021  |  North America  |  Frost Radar
Frost Radar™: Global Negative Pressure Wound Therapy Technology Devices, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Wounds, especially chronic wounds, are associated with clinical, social, and economic challenges. Wounds resulting from diabetes, injuries, and surgeries affect a significant population globally. According to an economic evaluation study on Medicare beneficiaries, 8.2 million people in the United States have at least one type of chronic wound. Amon...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Nov 2021  |  Global  |  Frost Radar
Frost Radar™: Global RNA Delivery Technologies, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The year 2018 was a breakthrough period for RNA therapeutics as the first RNA therapy received approval from the FDA. In the wake of the COVID-19 pandemic, RNA vaccines have witnessed immense progress and acceptance globally. These events have contributed massively to growth across the RNA therapeutics market. Currently, several RNA therapeutic...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Oct 2021  |  Global  |  Customer Research
Hybrid and Multicloud Healthcare IT Transformation
Findings from the 2020 Frost & Sullivan Global Cloud User Survey
Healthcare providers are accelerating digitization strategies due to the COVID-19 pandemic. The most successful providers leverage cloud computing to meet business agility, cost savings, innovation, data storage, security, and privacy goals. Frost & Sullivan conducted the 2020 Global Cloud User Survey between August and September 2020 in North A...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Aug 2021  |  North America  |  Frost Radar
Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021
A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines
During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Jun 2021  |  North America  |  Frost Radar
Frost Radar™: Digital Operating Rooms, 2020
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Jun 2021  |  North America  |  Frost Radar
Frost Radar™: US Population Health Management Market, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
After pausing while the US healthcare industry struggled to contain COVID-19, the stringent audit process for value-based care (VBC) is back in full swing for 90% of Medicare reimbursement that is currently attributed to some form of quality or risk-based payment plan. Additionally, CMS has launched new guidance for value-based reimbursement among ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Apr 2021  |  North America  |  Tracker
US COVID-19 Vaccines and Therapeutics Tracker—Market Insights and Trends, H1 2021
Agnostic Vaccine Platform Technology Enhancing Future Growth Potential of Participants in the Value Chain
This study by Frost & Sullivans Healthcare and Life Sciences team provides critical insights into the US COVID-19 vaccines and therapeutics market, including developing vaccines, supply chain considerations, and requirements to manage distribution. The study also identifies actionable and profitable growth opportunities for industry participants. T...
$2,450.00
Special Price $1,837.50 save 25 %
-
26 Mar 2021  |  North America  |  Customer Research
Global Laboratory Product Purchasing Trends, 2020–2021
An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents yea...
$4,950.00
Special Price $3,712.50 save 25 %